Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Hanx Biopharmaceuticals set to begin US clinical trial of HX009 in lymphoma Hanx Biopharmaceuticals (HanxBio) has obtained approval from the US Food and Drug Administration (FDA) for its investigational new… byPallavi MadhirajuMay 22, 2023